Schefold JC, Filippatos G, Hasenfuss G, Anker SD, von Haehling S. Heart failure and kidney dysfunction: epidemiology, mechanisms and management. Nat Rev Nephrol. 2016;12:610–23.

Article  CAS  PubMed  Google Scholar 

Damman K, Navis G, Voors AA, Asselbergs FW, Smilde TD, Cleland JG, et al. Worsening renal function and prognosis in heart failure: systematic review and meta-analysis. J Card Fail. 2007;13:599–608.

Article  PubMed  Google Scholar 

Ljungman S, Laragh JH, Cody RJ. Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function. Drugs. 1990;39:10–21.

Article  PubMed  Google Scholar 

Mullens W, Abrahams Z, Francis GS, Sokos G, Taylor DO, Starling RC, et al. Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. J Am Coll Cardiol. 2009;53:589–96.

Article  PubMed  PubMed Central  Google Scholar 

Anand IS. Cardiorenal syndrome: a cardiologist’s perspective of pathophysiology. Clin J Am Soc Nephrol. 2013;8:1800–7.

Article  PubMed  PubMed Central  Google Scholar 

Afsar B, Ortiz A, Covic A, Solak Y, Goldsmith D, Kanbay M. Focus on renal congestion in heart failure. Clin Kidney J. 2016;9:39–47.

Article  CAS  PubMed  Google Scholar 

Endo A, Hirose T, Sato S, Ito H, Takahashi C, Ishikawa R, et al. Sodium glucose cotransporter 2 inhibitor suppresses renal injury in rats with renal congestion. Hypertens Res. 2023 (e-pub ahead of print 20230925; https://doi.org/10.1038/s41440-023-01437-1).

Shimada S, Hirose T, Takahashi C, Sato E, Kinugasa S, Ohsaki Y, et al. Pathophysiological and molecular mechanisms involved in renal congestion in a novel rat model. Sci Rep. 2018;8:16808.

Article  PubMed  PubMed Central  Google Scholar 

van Ham WB, Kessler EL, Oerlemans M, Handoko ML, Sluijter JPG, van Veen TAB, et al. Clinical phenotypes of heart failure with preserved ejection fraction to select preclinical animal models. JACC Basic Transl Sci. 2022;7:844–57.

Article  PubMed  PubMed Central  Google Scholar 

Masuda T, Nagata D. Fluid homeostasis induced by sodium-glucose cotransporter 2 inhibitors: novel insight for better cardio-renal outcomes in chronic kidney disease. Hypertens Res. 2023;46:1195–201.

Article  CAS  PubMed  Google Scholar 

Zhuo M, Paik JM, Wexler DJ, Bonventre JV, Kim SC, Patorno E. SGLT2 inhibitors and the risk of acute kidney injury in older adults with type 2 diabetes. Am J Kidney Dis. 2022;79:858–0.e851.

Article  CAS  PubMed  Google Scholar 

Chung MC, Hung PH, Hsiao PJ, Wu LY, Chang CH, Hsiao KY, et al. Sodium-glucose transport protein 2 inhibitor use for type 2 diabetes and the incidence of acute kidney injury in Taiwan. JAMA Netw Open. 2023;6:e230453.

Article  PubMed  PubMed Central  Google Scholar 

Voors AA, Angermann CE, Teerlink JR, Collins SP, Kosiborod M, Biegus J, et al. The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial. Nat Med. 2022;28:568–74.

Article  CAS  PubMed  PubMed Central  Google Scholar